Communiqués Acrux Limited

Actions

ACR

AU000000ACR3

Produits pharmaceutiques

Marché Fermé - Australian S.E. Autres places de cotation 06:43:36 08/07/2026			Varia. 5j.	Varia. 1 janv.
0,0115 ^AUD	0,00%		-4,17%	-23,33%

28/05	Acrux cède la licence de Lenzetto pour le marché australien pour 5,4 millions de dollars australiens	RE
27/05	Le hongrois Richter et Acrux signent un accord de licence pour un spray d'estradiol transdermique en Australie	RE

Communiqués

23/05/22	Acrux : Application for quotation of securities - ACR	PU
14/04/22	Acrux : Application for quotation of securities - ACR	PU
15/03/22	Acrux : Application for quotation of securities - ACR	PU
25/02/22	Acrux : Updated Board Charter	PU
25/02/22	Acrux : Application for quotation of securities - ACR	PU
24/02/22	Acrux : Appendix 4D, Half Year Accounts as at 31 December 2021	PU
10/02/22	Acrux : Notification regarding unquoted securities - ACR	PU
10/02/22	Acrux : Application for quotation of securities - ACR	PU
16/12/21	Acrux : Whistleblower Policy	PU
26/11/21	Acrux : Notification regarding unquoted securities - ACR	PU
26/11/21	Acrux : Amendment to Constitution	PU
22/11/21	Acrux : Annual General Meeting Presentation and Addresses	PU
15/04/21	Acrux : Appendix 2AOpens in a new Window	PU
15/04/21	Acrux : fourth generic dossier accepted by FDA for reviewOpens in a new Window	PU
15/03/21	Acrux : Change of Director's Interest Notice - Ross DobinsonOpens in a new Window	PU
15/03/21	Acrux : Appendix 2AOpens in a new Window	PU
25/02/21	Acrux : Appendix 4D and Half Year Accounts - for the 31 Dec acOpens in a new Window	PU
25/02/21	Acrux : Investor PresentationOpens in a new Window	PU
15/02/21	Acrux : Appendix 2AOpens in a new Window	PU
05/02/21	Acrux : Amended Appendix 3Y - Geoff BrookeOpens in a new Window	PU
04/02/21	Acrux : Appendix 3GOpens in a new Window	PU
04/02/21	Acrux : Change of Director's Interest NoticeOpens in a new Window	PU
03/02/21	Acrux : Cleansing StatementOpens in a new Window	PU
03/02/21	Acrux : Appendix 2AOpens in a new Window	PU
02/02/21	Acrux : Appendix 2A - Share Purchase PlanOpens in a new Window	PU